Immunogenicity and Bioassay Summit

Distinguished Faculty


Immunogenicity Assessment & Clinical Relevance | Immunogenicity Prediction & Mitigation
Optimizing Bioassays for Biologics 




Immunogenicity Assessment & Clinical Relevance 


Lakshmi Amaravadi, Ph.D., Senior Director, Translational Medicine, Biogen Idec, Inc.

Paul Chamberlain, NDA Advisory Board

Niklas Czeloth, Global Biosimilars, Boehringer Ingelheim Pharma GmbH & Co KG

Rebecca Elliott, MSc, Manager, BioAnalytical Sciences, Genentech, Inc.

William Hallett, Ph.D., Product Quality & Immunogenicity Reviewer, CDER/OPQ/OBP FDA

Susan Kirshner, Ph.D., Associate Chief, Laboratory of Immunology, Therapeutic Proteins, Biotechnology, CDER/FDA

Amy Loercher, Ph.D., Manager, Clinical Immunology, GSKl

Jim McNally, Ph.D., Associate Director, PDM Immunogenicity Expert, EMD Serono

Laure Moller, Ph.D., Director, Scientific Support North America, Meso Scale Discovery

Per Holse Mygind, Ph.D., Senior Scientist, Immunogenicity Assessment, Novo Nordisk

Michael Partridge, Ph.D., Staff Scientist, Bioanalytical Sciences, Regeneron, Inc.

Bonita Rup, Ph.D., Biotechnology Consultant, Bonnie Rup Consulting LLC

Valerie Quarmby, Ph.D., Staff Scientist, BioAnalytical Sciences, Genentech, Inc.

Yongchang Qiu, Ph.D., Senior Director, Head, Bioanalytical and Biomarker Development, Research & Nonclinical Development, Shire

Theo Rispens, Ph.D., Senior Scientist, Immunopathology, Sanquin

Jianyong (Jerry) Wang, Ph.D., Scientist, Biochemical and Cellular Pharmacology, Genentech, Inc.

Yuling Wu, Ph.D., Principal Scientist, Translational Sciences, MedImmune


Immunogenicity Prediction & Mitigation 


Naren Chirmule, Ph.D., Vice President, Scientific Research, Biocon

Karl Griswold, Ph.D., Associate Professor, Thayer School of Engineering, Dartmouth

Tim Hickling, Ph.D., Associate Research Fellow, Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc. 

Marisa Joubert, Ph.D., Senior Scientist, Process Development, Amgen, Inc.

Zoheb Kazi, MBBS, Postdoctoral Research Associate, Pediatrics/Medical Genetics, Duke University Medical Center

Kei Kishimoto, Ph.D., CSO, Selecta Biosciences

Emilee Knowlton, D.Phil., Immunology Sales Specialist, ProImmune

Stephan Kontos, Ph.D., Co-Founder, Director, Research, Anokion

Atanas Koulov, Ph.D., Group Head, Pharma Technical Development Europe (Biologics), Analytics, F. Hoffmann-La Roche Ltd.

Matthew Macauley, Ph.D., Assistant Professor, Chemical Physiology, Scripps Research Institute

Ira Pastan, M.D., Co-Chief, Molecular Biology, National Cancer Institute, National Institutes of Health

Jack Ragheb, Ph.D., Principal Investigator, Therapeutic Proteins, CDER/FDA

Amy S. Rosenberg, M.D., Division Director, Office of Biotechnology Products, FDA

David W. Scott, Ph.D., Professor and Vice Chair for Research, Department of Medicine (MED), Uniformed Services University of Health Sciences

Daniela Verthelyi, M.D., Ph.D., Chief, Immunology Lab, CDER/OBP/FDA


Optimizing Bioassays for Biologics 


Camille Dycke, Ph.D., Associate Director, Biological Assays, MMTech, Global Biologics QC at Genentech 

Laura Geagan, Principal Research Associate, Bioanalytical Development, Genzyme

Florence Guilhot, Ph.D., Head, Translational Pharmacology Lab, NovImmune SA

Darshana Jani, Ph.D., Senior Manager, Pfizer 

Brenna Kelley-Clark, Ph.D., Scientist II, Assay Development, Immune Design

Maura C. Kibbey, Ph.D., Senior Scientific Liaison, Biologics & Biotechnology, United States Pharmacopeia

Seema Kumar, Ph.D., Principal Scientist, Pfizer, Inc.

John M. Lehrach, Research Scientist II, Bristol-Meyers Squibb 

Shihua Lin, Ph.D., Analytical Biotechnology Development, MedImmune LLC 

LiNa Loo, Ph.D., Senior Scientist, Bioanalytical Development, Merck

Xiaobin (Victor) Lu, Ph.D., Biologist, Virology Interest Group, CBER-FDA

Max L. Tejada, Ph.D., SRSII, Gilead Sciences

Piyush M. Vyas, Ph.D., Research Scientist, Bioassay Development, Eli Lilly and Company 

Ray Zhang, Ph.D., Research Investigator, Bristol-Meyers Squibb 




Immunogenicity Assessment & Clinical Relevance | Immunogenicity Prediction & Mitigation
Optimizing Bioassays for Biologics 

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 


Register Now 


 2014 Brochure Cover 

Podcast 

IMN Podcast iconReducing and Monitoring Bioassay Variability 

2013 Speaker: Janet L. Lathey, Ph.D., Director, Immunology and Assay Development, BioDefenseDivision, Emergent BioSolutions